| Name | Title | Contact Details |
|---|
InnFocus, Inc., an early stage company pioneering a microsurgical solution for glaucoma.InnFocus is an ophthalmology company founded in 2003 with extensive biomaterials experience that develops and provides next generation products for glaucoma surgery. Glaucoma is a disease for which there is no cure, is the second leading cause of blindness in the world and afflicts an estimated 60 million people worldwide.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Integrated Behavioral Health (IBH) provides innovative technology based tools and effective treatments for employee assistance, workers compensation programs, substance abuse and opioid addiction, behavioral health, and wellness management. For over 35 years, IBH serves over 38K employers and supports 10 million employees and their families. With a focus on positive outcomes through clinically validated methods and tools, IBH reduces claims and costs for organizations while improving the lives of its people.
Capital Senior Living Corporation is one of the nation`s largest operators of residential communities for senior adults. With a goal of offering affordable housing and an enriched lifestyle to thousands of seniors, our dedicated team of professionals succeeds in providing quality care in each of our unique communities.
Mena Regional Health System is a Mena, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.